Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» bulimia nervosa
bulimia nervosa
Opiant’s Mid-Stage Treatment for a Severe Eating Disorder Fails to Reach Endpoints
BioSpace
Fri, 02/22/19 - 11:43 am
Opiant Pharmaceuticals
bulimia nervosa
eating disorders
Narcan